Myo-Inositol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy by Inhibiting PI3K/AKT Activation-Reference-Cited by-同舟云学术

Myo-Inositol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy by Inhibiting PI3K/AKT Activation

Published:2023-06-01 Issue:6 Volume:26 Page:368-378
ISSN:1096-620X
Container-title:Journal of Medicinal Food
language:en
Short-container-title:Journal of Medicinal Food

Author:

Hu Xiaofang¹,Yang Ming²,Li Xiangyi³,Gong Zhicheng⁴,Duan Jianxiu⁵

Affiliation:

1. Department of Clinical Medicine, School of Medicine, Hunan Normal University, Changsha, China.

2. Department of Nephrology, Zhuzhou Central Hospital, Zhuzhou, China.

3. Department of Nephrology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan, China.

4. Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.

5. Department of Clinical Trial Research Center, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan, China.

Publisher

Mary Ann Liebert Inc

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.liebertpub.com/doi/pdf/10.1089/jmf.2022.K.0152

Reference38 articles.

1. Chronic Kidney Disease Diagnosis and Management

2. Sinomenine attenuates renal fibrosis through Nrf2-mediated inhibition of oxidative stress and TGFβ signaling

3. The fibrogenic niche in kidney fibrosis: components and mechanisms

4. Treatment of Renal Fibrosis—Turning Challenges into Opportunities

5. Suramin Inhibits Renal Fibrosis in Chronic Kidney Disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral supplementation of inositols effectively recovered lithium-induced cardiac dysfunctions in mice;Biomedicine & Pharmacotherapy;2024-09